EZH2 and breast cancer: Although certain BC cell lines showed impaired or unchanged proliferation upon EZH2 inhibition, knockdown of EZH2 in the MDA-MB-468 TNBC cell line stimulated the growth properties of the cells, with an even more pronounced effect under CAF treatment (Fig. S3A and B).